Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-24 Purchase | 2026-06-26 7:40 pm | Faeth Therapeutics Inc. | FTH | STEPHENSON BRIAN C Chief Financial Officer | 15,641 | $25.65 | $401,269 | 33,054 (Indirect) | View |
| 2026-06-22 Purchase | 2026-06-24 6:58 pm | Faeth Therapeutics Inc. | FTH | STEPHENSON BRIAN C Chief Financial Officer | 17,413 | $23.31 | $405,921 | 17,413 (Indirect) | View |
| 2026-06-22 Purchase | 2026-06-24 6:55 pm | Faeth Therapeutics Inc. | FTH | Parikh Anand Kiran President and CEO | 2,806 | $19.76 | $55,447 | 913,438 (Direct) | View |
| 2026-06-01 Sale | 2026-06-01 5:21 pm | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 25,000 | $20.02 | $500,543 | 130,142 (Direct) | View |
| 2026-06-01 Sale | 2026-06-01 5:20 pm | Sensei Biotherapeutics Inc. | SNSE | Peyer James See remarks below 10% Owner | 25,000 | $20.02 | $500,543 | 130,142 (Direct) | View |
| 2026-04-02 Purchase | 2026-05-15 4:24 pm | Sensei Biotherapeutics Inc. | SNSE | MILLENNIUM MANAGEMENT LLC ICS OPPORTUNITIES II LLC MILLENNIUM GROUP MANAGEMENT LLC ENGLANDER ISRAEL A 10% Owner | 4,215 | $33.54 | $141,364 | 133,986 (Indirect) | View |
| 2026-04-02 Sale | 2026-05-15 4:24 pm | Sensei Biotherapeutics Inc. | SNSE | MILLENNIUM MANAGEMENT LLC ICS OPPORTUNITIES II LLC MILLENNIUM GROUP MANAGEMENT LLC ENGLANDER ISRAEL A 10% Owner | 17,076 | $31.51 | $538,114 | 133,986 (Indirect) | View |
| 2026-03-31 Purchase | 2026-05-15 4:22 pm | Sensei Biotherapeutics Inc. | SNSE | MILLENNIUM MANAGEMENT LLC ICS OPPORTUNITIES II LLC MILLENNIUM GROUP MANAGEMENT LLC ENGLANDER ISRAEL A 10% Owner | 12,180 | $31.37 | $382,100 | 147,731 (Indirect) | View |
| 2026-03-31 Sale | 2026-05-15 4:22 pm | Sensei Biotherapeutics Inc. | SNSE | MILLENNIUM MANAGEMENT LLC ICS OPPORTUNITIES II LLC MILLENNIUM GROUP MANAGEMENT LLC ENGLANDER ISRAEL A 10% Owner | 2,741 | $28.07 | $76,949 | 147,731 (Indirect) | View |
| 2026-03-26 Purchase | 2026-05-15 4:22 pm | Sensei Biotherapeutics Inc. | SNSE | MILLENNIUM MANAGEMENT LLC ICS OPPORTUNITIES II LLC MILLENNIUM GROUP MANAGEMENT LLC ENGLANDER ISRAEL A 10% Owner | 30,585 | $26.75 | $818,257 | 145,678 (Indirect) | View |
| 2026-03-26 Sale | 2026-05-15 4:22 pm | Sensei Biotherapeutics Inc. | SNSE | MILLENNIUM MANAGEMENT LLC ICS OPPORTUNITIES II LLC MILLENNIUM GROUP MANAGEMENT LLC ENGLANDER ISRAEL A 10% Owner | 3,250 | $27.5 | $89,390 | 145,678 (Indirect) | View |
| 2025-12-09 Sale | 2025-12-10 4:56 pm | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 6,612 | $8.2539 | $54,575 | 155,142 (Direct) | View |
| 2025-12-08 Sale | 2025-12-10 4:52 pm | Sensei Biotherapeutics Inc. | SNSE | Peyer James See remarks below 10% Owner | 6,612 | $8.2539 | $54,575 | 155,142 (Indirect Direct) | View |
| 2025-12-04 Sale | 2025-12-08 4:39 pm | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 21,295 | $10.93 | $232,690 | 161,359 (Direct) | View |
| 2025-12-04 Sale | 2025-12-08 4:36 pm | Sensei Biotherapeutics Inc. | SNSE | Peyer James See remarks below 10% Owner | 21,295 | $10.93 | $232,690 | 161,359 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-22 Exercise | 2026-06-24 6:55 pm | N/A N/A | Faeth Therapeutics Inc. | FTH | Parikh Anand Kiran President and CEO | 53,465 | $1.16 | 913,438 (Direct) | View |
| 2026-06-22 Exercise | 2026-06-24 6:55 pm | N/A 2035-12-01 | Faeth Therapeutics Inc. | FTH | Parikh Anand Kiran President and CEO | 53,465 | $0 | 913,438 (Direct) | View |
Ownership | 2026-06-23 5:21 pm | N/A 2036-03-10 | Faeth Therapeutics Inc. | FTH | STEPHENSON BRIAN C Chief Financial Officer | 0 | $0 | 166,435 (Direct) | View |
| 2026-06-12 Option Award | 2026-06-16 4:49 pm | N/A 2036-06-11 | Sensei Biotherapeutics Inc. | FTH | Ramasastry Saira Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2026-06-15 Conversion | 2026-06-16 4:38 pm | N/A N/A | Sensei Biotherapeutics Inc. | FTH | Parikh Anand Kiran President and CEO | 762,189 | $0 | 761,428 (Direct) | View |
Ownership | 2026-06-16 4:23 pm | N/A 2036-01-24 | Sensei Biotherapeutics Inc. | FTH | Ramasastry Saira Director | 0 | $0 | 14,647 (Direct) | View |
| 2026-06-12 Option Award | 2026-06-16 4:21 pm | N/A 2036-06-11 | Sensei Biotherapeutics Inc. | FTH | Hahn Stephen M. Director | 25,000 | $0 | 69,763 (Direct) | View |
| 2026-06-15 Conversion | 2026-06-16 4:21 pm | N/A N/A | Sensei Biotherapeutics Inc. | FTH | Hahn Stephen M. Director | 44,808 | $0 | 69,763 (Direct) | View |
Ownership | 2026-06-16 4:18 pm | N/A N/A | Sensei Biotherapeutics Inc. | FTH | Hahn Stephen M. Director | 0 | $0 | 44,763 (Direct) | View |
| 2026-02-17 Option Award(A) | 2026-06-16 4:16 pm | N/A N/A | Sensei Biotherapeutics Inc. | FTH | Parikh Anand Kiran President and CEO | 149,965 | $0 | 910,632 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 9:12 pm | N/A 2036-06-09 | Sensei Biotherapeutics Inc. | SNSE | Gerry Christopher President & PEO | 220,000 | $0 | 220,000 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 8:35 pm | N/A 2036-06-09 | Sensei Biotherapeutics Inc. | SNSE | Donenberg Phillip B. Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 8:33 pm | N/A 2036-06-09 | Sensei Biotherapeutics Inc. | SNSE | Holmen Bob Director | 12,500 | $0 | 12,500 (Direct) | View |
Ownership | 2026-05-15 4:21 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | MILLENNIUM MANAGEMENT LLC ICS OPPORTUNITIES II LLC MILLENNIUM GROUP MANAGEMENT LLC ENGLANDER ISRAEL A 10% Owner | 0 | $0 | 127,095 (Indirect) | View |
| 2026-04-10 Option Award | 2026-04-14 5:18 pm | N/A 2036-04-09 | Sensei Biotherapeutics Inc. | SNSE | Craver Josiah PFO & PAO | 80,000 | $0 | 80,000 (Direct) | View |
| 2026-04-10 Option Award | 2026-04-14 5:15 pm | N/A 2036-04-09 | Sensei Biotherapeutics Inc. | SNSE | Donenberg Phillip B. Director | 23,100 | $0 | 23,100 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 9:45 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | Parikh Anand Kiran Chief Operating Officer | 2,198,333 | $0 | 2,198,333 (Direct) | View |
| 2026-02-13 Option Award | 2026-02-17 5:01 pm | N/A 2036-02-12 | Sensei Biotherapeutics Inc. | SNSE | Donenberg Phillip B. Director | 1,900 | $0 | 1,900 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-10 4:56 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 395 | $6.4 | 155,142 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-10 4:56 pm | N/A 2035-05-20 | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 395 | $0 | 155,142 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-10 4:52 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | Peyer James See remarks below 10% Owner | 395 | $6.4 | 155,142 (Indirect) | View |
| 2025-12-09 Exercise | 2025-12-10 4:52 pm | N/A 2035-05-20 | Sensei Biotherapeutics Inc. | SNSE | Peyer James See remarks below 10% Owner | 395 | $0 | 155,142 (Direct) | View |
Ownership | 2025-11-24 7:01 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | Gerry Christopher President & PEO | 0 | $0 | 19,804 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-23 4:30 pm | N/A 2035-05-20 | Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner | 19,000 | $0 | 19,000 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-23 4:30 pm | N/A 2035-05-20 | Sensei Biotherapeutics Inc. | SNSE | RICKS THOMAS G Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-23 4:30 pm | N/A 2035-05-20 | Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner | 19,000 | $0 | 19,000 (Indirect) | View |
| 2025-05-21 Option Award | 2025-05-23 4:30 pm | N/A 2035-05-20 | Sensei Biotherapeutics Inc. | SNSE | Humer Kristian Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-23 4:30 pm | N/A 2035-05-20 | Sensei Biotherapeutics Inc. | SNSE | Holmen Bob Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-23 4:30 pm | N/A 2035-05-20 | Sensei Biotherapeutics Inc. | SNSE | RINGO WILLIAM R Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2025-02-19 Tax Withholding | 2025-02-26 6:45 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | Celebi John PRESIDENT AND CEO | 5,558 | $0.476 | 105,862 (Direct) | View |
| 2025-02-19 Tax Withholding | 2025-02-26 6:44 pm | N/A N/A | Sensei Biotherapeutics Inc. | SNSE | van der Horst Edward CHIEF SCIENTIFIC OFFICER | 2,276 | $0.476 | 59,794 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-14 6:06 pm | N/A 2035-02-13 | Sensei Biotherapeutics Inc. | SNSE | Krebs Stephanie Chief Business Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-14 6:04 pm | N/A 2035-02-13 | Sensei Biotherapeutics Inc. | SNSE | Craver Josiah Principal Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |